OverviewChartNewsTraderScreen

BNP Paribas Knock-Out ABBV/  DE000PC6DY34  /

Frankfurt Zert./BNP
2024-05-17  2:50:28 PM Chg.-0.010 Bid2024-05-17 Ask2024-05-17 Underlying Strike price Expiration date Option type
8.730EUR -0.11% 8.730
Bid Size: 13,000		 8.780
Ask Size: 13,000		 AbbVie Inc 259.1134 USD 2078-12-31 Put
GlobeNewswire 1:12 PM INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 05-16 Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
GlobeNewswire 05-14 CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire 05-14 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 05-14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 05-14 In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit
GlobeNewswire 05-13 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 05-11 SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC
GlobeNewswire 05-09 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire 05-09 Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...
GlobeNewswire 05-08 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 05-08 Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire 05-08 ArriVent BioPharma Reports First Quarter 2024 Financial Results
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-07 Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-06 Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire 05-02 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 05-02 Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...